Seeing Is Believing
INO is currently covered by 6 analysts with an average price target of $14.4. This is a potential upside of $12.67 (732.37%) from yesterday's end of day stock price of $1.73.
Inovio Pharmaceuticals's activity chart (see below) currently has 96 price targets and 114 ratings on display. The stock rating distribution of INO is 57.89% HOLD and 42.11% BUY.
Analysts average stock forecasts to be materialized ratio is 73.34% with an average time for these price targets to be met of 495.25 days.
Highest price target for INO is $18, Lowest price target is $3, average price target is $10.13.
Most recent stock forecast was given by GREGORY RENZA from RBC on 19-Mar-2025. First documented stock forecast 18-Jun-2014.
Currently out of the existing stock ratings of INO, 11 are a HOLD (57.89%), 8 are a BUY (42.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
$3.27 (189.02%)
$6
11 days ago
(19-Mar-2025)
13/19 (68.42%)
$3.04 (155.10%)
417
Hold
$3
$1.27 (73.41%)
$3
11 days ago
(19-Mar-2025)
3/7 (42.86%)
$1.04 (53.06%)
1200
Buy
$18
$16.27 (940.46%)
16 days ago
(14-Mar-2025)
1/2 (50%)
$15.97 (786.70%)
67
Buy
$15
$13.27 (767.05%)
$33
4 months 12 days ago
(18-Nov-2024)
2/5 (40%)
$10.92 (267.65%)
367
Buy
$15
$13.27 (767.05%)
$33
4 months 12 days ago
(18-Nov-2024)
0/2 (0%)
$10.92 (267.65%)
What is INO (Inovio Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?
Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?
Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?